Q & A: FDA Regulatory Actions on COX-2 Inhibitors & NSAIDs

Part 5 of 5 - On April 7, 2005, FDA Announced Planned Regulatory Actions

Question #17) If I’m taking Bextra, what should I do?

We encourage people taking Bextra to contact their physician to discuss discontinuing use and alternative treatments. Any decision about which drug product to take to treat your symptoms should be made in consultation with your physician based on an assessment of your specific treatment needs.

Question #18) If I have rheumatoid arthritis, what pain medication does FDA recommend?

You should consult your doctor to discuss the best course of action.

Call Drug Information at: 888-INFO-FDA (888-463-6332)

Question #19) How can I report serious side effects with COX-2 selective and non-selective NSAIDs to FDA?

FDA encourages anyone aware of a serious adverse reaction to make a MedWatch report. You can report an adverse event in two ways:

Question #20) Where can I get more information?

To find out more about all NSAIDs from FDA:

Visit our Drug Information web page at: www.fda.gov/cder

Call Drug Information at: 888-INFO-FDA (888-463-6332)

_{Source: Questions and Answers: FDA Regulatory Actions for the COX-2 Selective and Non-Selective Non-Steroidal Anti-inflammatory drugs (NSAIDs), FDA/Center for Drug Evaluation and Research, April 7, 2005}

Go Back To Part 1 --- FDA Regulatory Actions --->

• 1
• 2
• 3
• 4
• 5